134 related articles for article (PubMed ID: 33371813)
1. Ginsenoside Rg3 Suppresses Epithelial-Mesenchymal Transition via Downregulating Notch-Hes1 Signaling in Colon Cancer Cells.
Li X; Liu W; Geng C; Li T; Li Y; Guo Y; Wang C
Am J Chin Med; 2021; 49(1):217-235. PubMed ID: 33371813
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition.
Wang D; Wu C; Liu D; Zhang L; Long G; Hu G; Sun W
Biomed Res Int; 2019; 2019():8407683. PubMed ID: 30915362
[TBL] [Abstract][Full Text] [Related]
6. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 targets HIF-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells.
Liu T; Zhao L; Zhang Y; Chen W; Liu D; Hou H; Ding L; Li X
PLoS One; 2014; 9(9):e103887. PubMed ID: 25197976
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells.
Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y
Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.
Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J
Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005
[TBL] [Abstract][Full Text] [Related]
11. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
[TBL] [Abstract][Full Text] [Related]
12. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
[TBL] [Abstract][Full Text] [Related]
15. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY
J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells.
Song JH; Eum DY; Park SY; Jin YH; Shim JW; Park SJ; Kim MY; Park SJ; Heo K; Choi YJ
PLoS One; 2020; 15(10):e0240533. PubMed ID: 33091036
[TBL] [Abstract][Full Text] [Related]
17. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
18. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
19. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.
Wang T; Xuan X; Pian L; Gao P; Hu H; Zheng Y; Zang W; Zhao G
Tumour Biol; 2014 Feb; 35(2):1193-201. PubMed ID: 24022665
[TBL] [Abstract][Full Text] [Related]
20. The implication of Numb-induced Notch signaling in endothelial-mesenchymal transition of diabetic nephropathy.
Liu W; Wu Y; Yu F; Hu W; Fang X; Hao W
J Diabetes Complications; 2018 Oct; 32(10):889-899. PubMed ID: 30097225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]